HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

German OTC Market Woes Continue

Executive Summary

Germany's OTC market blues continue as the coronavirus lockdown bites into May. 

You may also be interested in...



German OTC Market 2021: Firms Must Adapt To New E-Commerce And Product Portfolio Realities

In Germany, the coronavirus accelerated the shift towards online pharmacy and has strengthened certain OTC categories in 2020. Sales of hand sanitizers and vitamin and mineral supplements jumped while cough, cold and flu purchases weakened. Exploring the 2020 data, Sempora Consulting offers its advice for companies looking to adapt their strategies to the new reality. 

Post-COVID Strategy: Invest, Don’t Save, Even If There's A Second Lockdown

What should consumer health companies be doing as Europe comes out of lockdown? Invest in key brands, says Sempora Consulting's managing partner Tobias Brodtkorb, and consider seizing the opportunity presented by the long-term trend for natural OTCs, which has been accelerated by the coronavirus pandemic. 

German OTC Marketing Round-Up: Allergy Launches From Novartis, Hevert, Dermapharm And Bencard

OTC marketing news from Germany: A hard-won desloratadine launch from Novartis, two new products from Dermapharm, as well as homeopathic and probiotic alternatives from Hevert and Bencard. 

Related Content

Topics

UsernamePublicRestriction

Register

LL005491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel